| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/17/2004 | WO2004051265A2 Fish disease models and uses thereof |
| 06/17/2004 | WO2004051222A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/17/2004 | WO2004050939A2 Plasma-assisted melting |
| 06/17/2004 | WO2004050908A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 06/17/2004 | WO2004050899A2 Method for in vitro selection of 2’-substituted nucleic acids |
| 06/17/2004 | WO2004050886A1 Packaging cell system for eb virus vector |
| 06/17/2004 | WO2004050885A2 Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide |
| 06/17/2004 | WO2004050883A2 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |
| 06/17/2004 | WO2004050882A1 Bioremediation with transgenic plants |
| 06/17/2004 | WO2004050881A2 A plant transcription factor that is involved in sugar signalling |
| 06/17/2004 | WO2004050880A2 Insecticidal agent |
| 06/17/2004 | WO2004050879A1 Expression vector, methods for the production of heterologous gene products, and selection method for high-producing recombinant cells |
| 06/17/2004 | WO2004050878A1 Method for modifying the expression of polypeptides in recombinant expression systems |
| 06/17/2004 | WO2004050877A1 L-rhamnose-inducible expression systems |
| 06/17/2004 | WO2004050876A1 A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof |
| 06/17/2004 | WO2004050875A1 Novel aromatic ring dioxygenase genes and use thereof |
| 06/17/2004 | WO2004050874A1 Germ-responsive promoter |
| 06/17/2004 | WO2004050873A1 Genetically modified plants expressing proteinase inhibitors, sapina2a or sapin2b, and methods of use thereof for the inhibition of trypsin-and chymotrypsin-like activities |
| 06/17/2004 | WO2004050871A1 Mixture of at least two fusion proteins, the production thereof and the use of the same |
| 06/17/2004 | WO2004050870A2 Genetic switches for the detection of fusion proteins |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050859A2 Homologous recombination in multipotent adult progenitor cells |
| 06/17/2004 | WO2004050858A2 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 06/17/2004 | WO2004050854A2 Methods for identifying the activity of gene products |
| 06/17/2004 | WO2004050847A2 Modified antibodies stably produced in milk and methods of producing same |
| 06/17/2004 | WO2004050844A2 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 06/17/2004 | WO2004050839A2 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 06/17/2004 | WO2004050838A2 Plant production of immunoglobulins with reduced fucosylation |
| 06/17/2004 | WO2004050829A2 Recombinant double-stranded rna phage, and use of the same |
| 06/17/2004 | WO2004050698A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/17/2004 | WO2004050695A2 Expression of polypeptides in filamentous fungi |
| 06/17/2004 | WO2004050694A1 Methods for the production of methionine |
| 06/17/2004 | WO2004050693A1 Engineering redox proteins |
| 06/17/2004 | WO2004050692A2 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production |
| 06/17/2004 | WO2004050691A2 A method for the production of hiv-1 gag virus-like particles |
| 06/17/2004 | WO2004050680A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 06/17/2004 | WO2004050679A2 Mutant glycoproteins |
| 06/17/2004 | WO2004050674A2 Methods and materials for modulating trpm2 |
| 06/17/2004 | WO2004050231A2 (bio) organic oligomers for the preparation of macromolecules |
| 06/17/2004 | WO2004050113A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 06/17/2004 | WO2004050027A2 Materials and methods for treating ocular-related disorders |
| 06/17/2004 | WO2004050017A2 Rationally designed antibodies |
| 06/17/2004 | WO2004049794A2 Single chain antibodies produced in a transgenic mouse |
| 06/17/2004 | WO2004049793A1 Model animal of cognitive learning disability with the use of leukemia inhibitory factor and method of constructing the same |
| 06/17/2004 | WO2004044003A3 Use of edg2 receptor in an animal model of heart failure |
| 06/17/2004 | WO2004035775A3 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 06/17/2004 | WO2004034013A8 Genotoxicity analysis |
| 06/17/2004 | WO2004033677A3 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 06/17/2004 | WO2004031767A3 Prevention of primary sjögren’s syndrome by ica69 deficiency |
| 06/17/2004 | WO2004031233A9 Novel chemokine-like polypeptides |
| 06/17/2004 | WO2004029223A9 Polynucleotide synthesis and labeling by kinetic sampling ligation |
| 06/17/2004 | WO2004029089A3 Novel angiogenesis target and uses thereof |
| 06/17/2004 | WO2004022756A3 Protein kinases |
| 06/17/2004 | WO2004016742A3 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 06/17/2004 | WO2004015075A3 SHORT INTERFERING RNAs HAVING A HAIRPIN STRUCTURE CONTAINING A NON-NUCLEOTIDE LOOP |
| 06/17/2004 | WO2004009763A3 Use of vaccinia virus deleted for the e3l gene as a vaccine vector |
| 06/17/2004 | WO2004007742A3 Chromosome 6 and 9 genes involved in premature canities |
| 06/17/2004 | WO2004007686A3 Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates |
| 06/17/2004 | WO2004003133A3 Pain signaling molecules |
| 06/17/2004 | WO2003102213A3 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003102017A3 Anti-relp fusion antibodies, compositions, methods and uses |
| 06/17/2004 | WO2003087145A3 Purified polypeptides involved in quorum sensing |
| 06/17/2004 | WO2003071281A3 Estrogen receptor interaction with a transcription factor |
| 06/17/2004 | WO2003064992A3 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 06/17/2004 | WO2003063770A9 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/17/2004 | WO2003062791A3 Detection of single nucleotide polymorphisms using planar waveguides |
| 06/17/2004 | WO2003059259A3 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003050259A3 Nucleic acids related to plant retroelements |
| 06/17/2004 | WO2003044165A3 Genetically modified bacterial strains and novel vectors for use in expressing and assaying natural products |
| 06/17/2004 | WO2003039341A3 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804 |
| 06/17/2004 | WO2003034073A3 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | WO2003022228A3 Method for producing transgenic birds and fish |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | WO2003015689A3 Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases |
| 06/17/2004 | WO2003000862A3 Homeotic genes and proteins, and uses thereof |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | WO2002079419A3 Identifying and characterizing genes |
| 06/17/2004 | WO2002064015A3 Pin1 as a marker for prostate cancer |
| 06/17/2004 | US20040117876 Dna; promoters for gene expression of plant cells |
| 06/17/2004 | US20040117875 Systems and methods for delivering interferon to a subject |
| 06/17/2004 | US20040117874 Genetic engineering; Dna construct with signal sequence |
| 06/17/2004 | US20040117872 Expression vector comprising nucleotide sequences coding arogenate dehydrogenase for transformation and propagation of glyphosate resistant plants |
| 06/17/2004 | US20040117871 Plant growth regulation |
| 06/17/2004 | US20040117870 Transgenic glyphosate resistant sugar beet; disease and herbicide resistant plants |
| 06/17/2004 | US20040117869 Comprises nucleotide sequences coding oxidoreductase for use in increasing nornicotine biosynthesis in plants |
| 06/17/2004 | US20040117868 Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same |
| 06/17/2004 | US20040117867 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 06/17/2004 | US20040117866 Novel transgenic zebrafish, gene fragments and methods for producing transgenic zebrafish |
| 06/17/2004 | US20040117865 Transposon generated genetically engineered rodent for use as tool in clarifying gene function; gene therapy and transposon mediated transformation |
| 06/17/2004 | US20040117863 Preparing genetically engineered polypeptide for diagnosis and treatment of cell proliferative disorders; cancer therapy and tumor targeting |
| 06/17/2004 | US20040117862 Production of high levels of transgenic factor VII with engineered stability and its therapeutic uses |
| 06/17/2004 | US20040117348 Sequence display method and homology search method for facilitating access to information relating to regions of mutation and regions of similarity between plurality of sequences |
| 06/17/2004 | US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
| 06/17/2004 | US20040116685 Method for solution phase synthesis of oligonucleotides |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116671 Novel polypeptides and nucleic acids encoding same |